Intrapartum and Early Postpartum Use of Automated Insulin Delivery in Type 1 Diabetes: A Prespecified Analysis of the CIRCUIT Randomized Controlled Trial

OBJECTIVE: Following the demonstrated improvement in pregnancy glycemia with Control-IQ closed loop in the Closed loop Insulin delivery by glucose Responsive Computer algorithms In Type 1 diabetes pregnancies (CIRCUIT) trial, we compared intrapartum and early postpartum glycemic effectiveness and safety with standard care in type 1 diabetes. RESEARCH DESIGN AND METHODS: The primary outcome of this prespecified analysis was percentage of time in pregnancy-specific glucose range (63-140 mg/dL) during the 24 h prior to childbirth, measured by continuous glucose monitoring. A key secondary outcome was percentage of time at <70 mg/dL in the first postpartum week, with additional secondary outcomes including continuous glucose monitoring metrics through 6 weeks postpartum. Analyses were adjusted for baseline measure, insulin delivery mode, and site. RESULTS: In the intrapartum period (24 h before delivery), 39 of 44 (89%) participants continued closed loop. Intravenous insulin was used intrapartum by one (2%) closed loop participant and 20 (45%) standard care participants (P < 0.001). Intrapartum closed loop users spent more time in pregnancy-specific glucose range (79.6% vs. 64.8%) than the standard-care group (mean adjusted difference 13.2 percentage points; 95% CI 5.2, 21.2). In the first postpartum week, the closed loop group spent less time <70 mg/dL (1.7% vs. 3.2%; mean adjusted difference -1.8 percentage points; 95% CI -0.9 to -2.7) compared with the standard care group. No maternal severe hypoglycemia occurred in the closed loop group, while one episode occurred in the standard care group postpartum. No diabetic ketoacidosis occurred in either group. CONCLUSIONS: Use of this closed loop system resulted in superior intrapartum and early postpartum glycemia compared with standard care, without safety concerns. Together with previous results, this supports use of this closed loop system throughout pregnancy, labor, and the early postpartum period.

Authors

Institutions

Publication Details

Journal
Diabetes Care
Published
2026-05-27
DOI
https://doi.org/10.2337/dc26-0470
Primary Topic
Gestational Diabetes Research and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intrapartum and Early Postpartum Use of Automated Insulin Delivery in Type 1 Diabetes: A Prespecified Analysis of the CIRCUIT Randomized Controlled Trial

Amy D. Dunlop, Suja Padmanabhan, Jane E. Booth, Khorshid Mohammad et al.
Diabetes Care
Gestational Diabetes Research and Management
article

Intrapartum and Early Postpartum Use of Automated Insulin Delivery in Type 1 Diabetes: A Prespecified Analysis of the CIRCUIT Randomized Controlled Trial

Amy D. Dunlop, Suja Padmanabhan, Jane E. Booth, Khorshid Mohammad, Denice S. Feig, Tamara Spaic, S Dg I M Crawford, Patricia Lemieux, Geetha Mukerji, Ariane Godbout, LOIS E. DONOVAN, Afshan Zahedi, Jason Kong, Bianca Cot, Jina Rhou, Sarah Price, George Tomlinson, Wah Cheung, Selina L. Liu, Thomas Ransom, Jillian Coolen, Glynis P. Ross, Chris Nolan, Jamie L. Benham, Ruth McManus, Arianne Sweeting, Julie McKeen, Kara A. Nerenberg, Ilana Halperin, Rhonda C. Bell, Alison Nankervis, Jennifer M. Yamamoto, Helen R. Murphy, David Simmons, Kathleen H. Chaput, Amita Mahajan, Hanan Bassyouni, Bruce A. Perkins, CIRCUIT Collaborative Group:
article en

Abstract

OBJECTIVE: Following the demonstrated improvement in pregnancy glycemia with Control-IQ closed loop in the Closed loop Insulin delivery by glucose Responsive Computer algorithms In Type 1 diabetes pregnancies (CIRCUIT) trial, we compared intrapartum and early postpartum glycemic effectiveness and safety with standard care in type 1 diabetes. RESEARCH DESIGN AND METHODS: The primary outcome of this prespecified analysis was percentage of time in pregnancy-specific glucose range (63-140 mg/dL) during the 24 h prior to childbirth, measured by continuous glucose monitoring. A key secondary outcome was percentage of time at <70 mg/dL in the first postpartum week, with additional secondary outcomes including continuous glucose monitoring metrics through 6 weeks postpartum. Analyses were adjusted for baseline measure, insulin delivery mode, and site. RESULTS: In the intrapartum period (24 h before delivery), 39 of 44 (89%) participants continued closed loop. Intravenous insulin was used intrapartum by one (2%) closed loop participant and 20 (45%) standard care participants (P < 0.001). Intrapartum closed loop users spent more time in pregnancy-specific glucose range (79.6% vs. 64.8%) than the standard-care group (mean adjusted difference 13.2 percentage points; 95% CI 5.2, 21.2). In the first postpartum week, the closed loop group spent less time <70 mg/dL (1.7% vs. 3.2%; mean adjusted difference -1.8 percentage points; 95% CI -0.9 to -2.7) compared with the standard care group. No maternal severe hypoglycemia occurred in the closed loop group, while one episode occurred in the standard care group postpartum. No diabetic ketoacidosis occurred in either group. CONCLUSIONS: Use of this closed loop system resulted in superior intrapartum and early postpartum glycemia compared with standard care, without safety concerns. Together with previous results, this supports use of this closed loop system throughout pregnancy, labor, and the early postpartum period.

Diabetes Care
University of East Anglia (GB), Western University (CA), Alberta Health Services (CA), Camden and Campbelltown Hospitals (AU), The University of Sydney (AU), University of Alberta (CA), University of Calgary (CA), University of Toronto (CA), Lunenfeld-Tanenbaum Research Institute (CA), Toronto General Hospital (CA), Alberta Children's Hospital (CA), UNSW Sydney (AU), Children's Hospital Research Institute of Manitoba (CA), Centre hospitalier de l'Université Laval (CA), Ingham Institute (AU), Institute for Work & Health (CA), Université Laval (CA), Libin Cardiovascular Institute of Alberta (CA)
Good health and well-being
Openalex Percentile: Top 6%
Gestational Diabetes Research and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.